Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
SHISEIDO SYNCHRO SKIN TINTED GEL CREAM
- Manufacturer
- SHISEIDO AMERICAS CORPORATION | SHISEIDO AMERICA INC.
- Effective date
- 2018-05-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:55:25
Label at a glance#
ProductSHISEIDO SYNCHRO SKIN TINTED 1 VERY LIGHT
Active ingredientOCTINOXATE, TITANIUM DIOXIDE
Label structure13 sections
Dosage and administration
For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the su...
Storage and handling
protect this product in this container from excessive heat and direct sun.
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| OCTINOXATE 2.9% | Sunscreen |
| TITANIUM DIOXIDE 6.1% | Sunscreen |
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
- children under 6 months: Ask a doctor
Inactive Ingredients
WATER•ISOHEXADECANE•PROPANEDIOL•ISOPROPYL MYRISTATE•TREHALOSE•ISODODECANE•ISOSTEARIC ACID•GLYCERIN•SILICA•POLYQUATERNIUM-51•THYMUS SERPYLLUM EXTRACT•SODIUM ACETYLATED HYALURONATE•CAMELLIA SINENSIS LEAF EXTRACT•METHYL METHACRYLATE/ACRYLONITRILE COPOLYMER•DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER•PEG-60 GLYCERYL ISOSTEARATE•AGAR•SORBITAN SESQUIISOSTEARATE•CELLULOSE GUM•ALUMINUM HYDROXIDE•POLYSILICONE-2•SODIUM CITRATE•ALCOHOL•MAGNESIUM HYDROXIDE•SUCCINOGLYCAN•BHT•BUTYLENE GLYCOL•TOCOPHEROL•CITRIC ACID•METHYL METHACRYLATE CROSSPOLYMER•SODIUM METABISULFITE•HYPERICUM ERECTUM FLOWER/LEAF/STEM EXTRACT•TALC•ALUMINA•POLYMETHYLSILSESQUIOXANE•ISOBUTANE•ISOPENTANE•PHENOXYETHANOL•TITANIUM DIOXIDE•IRON OXIDES•MICA•
Other information
- protect this product in this container from excessive heat and direct sun.
Questions or comments?
Call toll free 1-800-906-7503
PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton - 1 Very Light
SHISEIDO
GINZA TOKYO
SYNCHRO SKIN
Tinted Gel Cream
Oil Free
BROAD SPECTRUM
SPF 30
Sunscreen
40mL NET WT. 1.5 OZ.
PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton - 2 Light
SHISEIDO
GINZA TOKYO
SYNCHRO SKIN
Tinted Gel Cream
Oil Free
BROAD SPECTRUM
SPF 30
Sunscreen
40mL NET WT. 1.5 OZ.
PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton - 3 Medium
SHISEIDO
GINZA TOKYO
SYNCHRO SKIN
Tinted Gel Cream
Oil Free
BROAD SPECTRUM
SPF 30
Sunscreen
40mL NET WT. 1.5 OZ.
PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton - 4 Medium Dark
SHISEIDO
GINZA TOKYO
SYNCHRO SKIN
Tinted Gel Cream
Oil Free
BROAD SPECTRUM
SPF 30
Sunscreen
40mL NET WT. 1.5 OZ.
PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton - 5 Dark
SHISEIDO
GINZA TOKYO
SYNCHRO SKIN
Tinted Gel Cream
Oil Free
BROAD SPECTRUM
SPF 30
Sunscreen
40mL NET WT. 1.5 OZ.
FDA-Initiated Inactive NDC Indexing#
Products#
Every source-derived product name is available through these pages.
- SHISEIDO SYNCHRO SKIN TINTED 1 VERY LIGHT
- OCTINOXATE and TITANIUM DIOXIDE
- OCTINOXATE
- TITANIUM DIOXIDE
- WATER
- ISOHEXADECANE
- PROPANEDIOL
- ISOPROPYL MYRISTATE
- TREHALOSE
- ISODODECANE
- ISOSTEARIC ACID
- GLYCERIN
- SILICON DIOXIDE
- POLYQUATERNIUM-51 (2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE/N-BUTYL METHACRYLATE; 3:7)
- THYMUS SERPYLLUM
- SODIUM ACETYLATED HYALURONATE
- GREEN TEA LEAF
- DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)
- PEG-60 GLYCERYL ISOSTEARATE
- AGAR, UNSPECIFIED
- SORBITAN SESQUIISOSTEARATE
- CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM
- ALUMINUM HYDROXIDE
- SODIUM CITRATE, UNSPECIFIED FORM
- ALCOHOL
- MAGNESIUM HYDROXIDE
- BUTYLATED HYDROXYTOLUENE
- BUTYLENE GLYCOL
- .ALPHA.-TOCOPHEROL
- CITRIC ACID MONOHYDRATE
- SODIUM METABISULFITE
- HYPERICUM ERECTUM FLOWERING TOP
- TALC
- ALUMINUM OXIDE
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- ISOBUTANE
- ISOPENTANE
- PHENOXYETHANOL
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 58411-440 | 58411-440-60 |
| 58411-441 | 58411-441-60 |
| 58411-442 | 58411-442-60 |
| 58411-443 | 58411-443-60 |
| 58411-444 | 58411-444-60 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3221433a-08c1-4884-8e93-0150139b8095 | fd274403-3e35-4945-bce8-05b3ddb891bc | 2023-10-23 | Warnings | fd274403-3e35-4945-bce8-05b3ddb891bc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.